ハイアルーロナンの作用によるグリコカリクスの低下 がん細胞のマクロピノサイトーシスをp21のアップレギュレーションによって抑制する
Guangxin Luan1,2, Qian Guo1, Yiwen Liu1
1Department of Molecular Biology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Biomacromolecules
|September 3, 2025
まとめ
ハイアルロナンの関連グラコカリックス (HA-GCX) の厚さは,がん細胞のマクロピノサイトーシス (MP) と正の相関関係にある. HA-GCXを阻害すると,MPと癌細胞の増殖を抑制し,新たな治療目標を示唆する.
科学分野:
- 細胞生物学
- 癌 研究
- 生物化学
背景:
- マクロピノサイトーシス (MP) は,腫瘍の成長を支える,癌細胞における重要な栄養素吸収プロセスです.
- ハイアルロナンは細胞表面のグリコカリクスの重要な成分で,膜の動態に影響を与えます.
- MPにおけるHA関連グリコカリックス (HA-GCX) の調節的役割は,ほとんど未調査のままである.
研究 の 目的:
- 癌細胞におけるマクロピノサイトーシスの制御におけるHA- GCXの役割を調査する.
- HA-GCXとMPの活動を結びつける分子メカニズムを解明する.
- HA- GCXをがん治療の標的とする治療の可能性を評価する.
主な方法:
- 癌細胞におけるHA-GCXの厚さとMPの相関分析
- HA-GCXの実験的な破壊と,膜ラッフリングとMPへの影響の評価.
- CDKN1A/ p21とMMP1/9を標的とした遺伝子ノックダウン研究で,HA- GCX媒介のMP調節におけるその役割を評価した.
- HA-GCX分解後の癌細胞増殖の評価
主要な成果:
- HA-GCXの厚さは,がん細胞におけるMP活性と正の相関関係にある.
- HA-GCXの破壊は,膜のラフリングを減少させることで,MPを著しく抑制します.
- CDKN1A/ p21とMMP1/9のノックダウンにより,HA- GCXの除去後にMPの活性が回復する.
- HA- GCXの分解は,MPを阻害することによって,癌細胞の増殖を阻害する.
結論:
- HA-GCXは,がん細胞のマクロピノサイトーシスにおける新しい調節的役割を果たします.
- HA-GCX-CDKN1A/p21-MMP1/9軸は,MPに影響を与える重要な経路である.
- HA- GCXを標的とした治療は,がんの進行を抑制する潜在的治療戦略です.
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K


